ENHANCING ONCOLOGY RESEARCH WITH BUILT-IN KRAS ASSAY SOLUTIONS AND RAS ASSAYS

inside the quickly evolving industry of oncology investigation, exact and successful mutation screening is vital for developing specific therapies. The KRAS providers System plays a pivotal purpose In this particular landscape by presenting in depth methods for KRAS mutation profiling and Investigation. KRAS mutations, found in close to 95% of RAS-